I think we need to acknowledge that BobbyDazzler85 was right and everything has shifted out with PH2 Glaucoma now in 2023.
I am still hopeful of a big SP increase after the PH1 Study results are announced in Q3/Q4 2023. Until then patience required. Despite the hype of "Big Pharma" , I don't think that will happen yet either. But worth holding for another 12 months.
Ann: Investor Webinar Presentation, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.218M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66029 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 247043 | 2 |
View Market Depth
| Last trade - 10.06am 24/07/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable